Forum: her2group
11-01-2010, 09:33 AM
|
Replies: 19
Views: 3,450
|
Forum: her2group
10-21-2010, 07:07 PM
|
Replies: 19
Views: 3,450
Re: What's the latest on TDM1?
Early stages both preclinical and clinical of Genentech’s effort to develop T-DM1 as a new treatment for 3-line Her2+ metastatic breast cancer occurred when Susan Desmond-Hellman, now chancellor at...
|